PLASMONIC NANOPARTICLES WITH HIDDEN CHIROPTICAL ACTIVITY
20170184497 ยท 2017-06-29
Inventors
Cpc classification
C23C14/16
CHEMISTRY; METALLURGY
C23C14/226
CHEMISTRY; METALLURGY
G01N21/554
PHYSICS
International classification
C23C14/16
CHEMISTRY; METALLURGY
Abstract
A method is presented to minimize the helical pitch (P) of chiroplasmonic nanostructures to the molecular size-comparable scale. In particular, chiroplasmonic nanostructures can be used to induce plasmonic chirality via chirality transfer and used for chirality-related primary applications such as chiral sensing. In one aspect, there is provided a chiroptically active plasmonic nanoparticle with a helical pitch (P) less than its wire diameter (d) produced via a glancing angle deposition (GLAD) process.
Claims
1. A chiroptically active plasmonic nanoparticle with a helical pitch (P) less than its wire diameter (d) produced via a glancing angle deposition (GLAD) process.
2. The chiroptically active plasmonic nanoparticle according to claim 1 wherein said nanoparticle is chiroptically active in the UV-visible spectrum.
3. The chiroptically active plasmonic nanoparticle according to claim 1 wherein said nanoparticle is chiroptically active in the spectrum range between 330 nm to 700 nm.
4. The chiroptically active plasmonic nanoparticle according to claim 1 wherein said nanoparticle has hidden chirality.
5. The chiroptically active plasmonic nanoparticle according to claim 4 wherein the hidden chirality is controlled by substrate rotation wherein a counter clockwise rotation produces said nanoparticle with a left-handed chirality and a clockwise rotation produces said nanoparticle with a right-handed chirality.
6. The chiroptically active plasmonic nanoparticle according to claim 1 wherein said nanoparticle has a reversible water effect wherein when said nanoparticle is wet, its plasmonic mode is red shifted and amplified and said shifting and amplification of the plasmonic mode is reversed when said nanoparticle is dried.
7. The chiroptically active plasmonic nanoparticle according to claim 1 wherein said nanoparticle is a silver nanoparticle or a gold nanoparticle or a copper nanoparticle or an aluminum nanoparticle.
8. The chiroptically active plasmonic nanoparticle according to claim 7 wherein the nanoparticle is silver and the helical pitch (P) of said silver nanoparticle ranges between about 3.5 nm to about 70 nm and wherein the wire diameter (d) of said silver nanoparticle is no less than about 65 nm.
9. A method to produce a chiroptically active plasmonic nanoparticle with a helical pitch (P) less than its wire diameter (d) comprising a glancing angle deposition process with substrate rotation during deposition, wherein a counter clockwise rotation produces said nanoparticle with a left-handed chirality and a clockwise rotation produces said nanoparticle with a right-handed chirality.
10. The method according to claim 9 wherein the substrate used is silver or gold or copper or aluminum.
11. The method according to claim 10 wherein the helical pitch (P) of a silver nanoparticle produced ranges between about 3.5 nm to about 70 nm and wherein the wire diameter (d) of said silver nanoparticle is no less than about 65 nm.
12. The method according to claim 9 wherein said nanoparticle is chiroptically active in the UV-visible spectrum.
13. The method according to claim 9 wherein said nanoparticle is chiroptically active in the spectrum range between 330 nm to 700 nm.
14. The method according to claim 9 wherein said nanoparticle has hidden chirality.
15. The method according to claim 9 wherein a substrate temperature (T.sub.sub) used in said glancing angle deposition (GLAD) process is approximately 0 C. to approximately 70 C.
16. The method according to claim 9 wherein said nanoparticle has a reversible water effect wherein when said nanoparticle is wet, its plasmonic mode is redshifted and amplified and said shifting and amplification of the plasmonic mode is reversed when said nanoparticle is dried.
17. A chiral sensor including the chiroptically active plasmonic nanoparticle according to claim 1.
18. The chiral sensor of claim 17 wherein the chiroptically active plasmonic nanoparticle is positioned in a solvent.
19. The chiral sensor of claim 17 wherein the chiroptically active plasmonic nanoparticle is positioned in an aqueous solution.
20. The chiral sensor of claim 17 wherein chiroptically active plasmonic nanoparticle is positioned in a biological fluid.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0032] The above and other objects and features of the present invention will become apparent from the following description of the invention, when taken in conjunction with the accompanying drawings, in which:
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
DETAILED DESCRIPTION
[0053] The present invention is not to be limited in scope by any of the specific embodiments described herein. The following embodiments are presented for exemplification only.
[0054] Chiroptically active plasmonic nanoparticles with a helical pitch (P) less than a wire diameter (d) are produced via a glancing angle deposition (GLAD) process. Various metals may be used to form chiroptically active plasmonic nanoparticles including silver, gold, copper, and aluminum.
[0055] The GLAD process may be carried out in a commercially available physical vapor deposition system capable of sustaining a high vacuum of 10.sup.7-10.sup.6 Torr. Bulk starting materials, typically in the form of pellets, are used as evaporation sources. The source materials may be evaporated at rates of <0.5 nm/s as monitored by a quartz crystal microbalance. The electron-beam accelerating voltage may range from 5 to 10 kV with an emission current of 10-100 mA. Glancing deposition angles of 70 to 87 with respect to the direction normal to the substrate may be used. A variety of substrates including insulators such as sapphire, semiconductors such as silicon, and metals such as silver, gold, copper, or aluminum may be used. During deposition, an ethanol/water cooling system may be used to control the substrate temperature. Substrate temperatures ranging from room temperature to roughly 70 C. may be used during deposition. To produce right-handed or left-handed nanoparticles, the substrate is rotated clockwise/counterclockwise at a rate R.sub.r (in units of degrees per second, or /s) given by
where R.sub.d is the deposition rate on the substrate surface and P is the helical pitch. The nominal P was calibrated by
where H is the helix height controlled to be roughly 100 nm, and n is the number of helical pitches equal to the number of circles in which the substrate was rotated. Details of a particular embodiment for silver nanoparticles is set forth in Example 1 below. The discussion of silver nanoparticles in the detailed description is based on the silver nanoparticles fabricated in Example 1.
[0056] Silver nanoparticles (AgNPs) with nominal P (in a range of 3-70 nm per revolution) smaller than d, were fabricated in Example 1, breaking the helix-geometrical limit. Apparently achiral nanoparticles have hidden helicity, resulting in chiroptical activity in the UV-visible spectrum. Hidden chiroptical activity in terms of circular dichroism (CD) and anisotropy g factor alters in sign with switching hidden helicity, and barely has a spectral shift but has a common logarithmical enhancement with nominal P. The nominal P can be minimized to as small as 4 nm with a reliably detectable chiroptical response.
[0057] GLAD enables a deposition of a close-packed random array of AgNPs appearing to have non-helical profile, with a fixed H of 100 nm and nominal P engineerable in a range of 3-70 nm per revolution (i.e., nm/rev,
[0058] where CD is the ellipticity (units: millidegree, or mdeg) and A is the extinction. The arrays have the plasmonic g factor of 410.sup.3 (
[0059] The chiral AgNP arrays, with a nominal P in the range of 3-70 nm and H of 100 nm, were spectroscopically characterized in the UV-visible region. The AgNP arrays have a P-independent extinction (
where CD.sub.max and g.sub.max represent the amplitude of CD and g factor at the wavelength of .sub.CD,max and .sub.g,max, respectively. The slope of the plasmonic mode varies in a small range of 0.021-0.026 nm.sup.1 with the hidden AgNP chirality, and is nearly equal to that of the shoulder plasmonic mode (
[0060] Chiral plasmons may be used for chirality-related determinations in analytical chemistry, pharmacology, and biology. Left-handed and right-handed versions of the same molecule, known as enantiomers, may significantly differ in their chemical and biological actions. In some cases, one enantiomer may have a therapeutic pharmacological activity while the other enantiomer may be hazardous. Consequently, it is important to be able to distinguish between enantiomers. Chiroptical methods typically measure small differences, or dissymmetries, in the interaction of left and right circularly polarized light, the chiral probe, with a chiral material to determine the enantiomer present. Chiral plasmons tend to amplify the chiroptical activity of enantiomers, leading to an enhancement of enantiomer differentiation.
[0061] In a recent referenced entitled Expanding the Chiral Toolbox: Recent chiral advances demonstrate promise for API synthesis by Cynthia A. Challener, Pharmaceutical technology, Volume 40, Issue 7, pages 28-29, Jul. 2, 2016 (retrieved from http://www.pharmtatech.com/expanding-chiral-toolbox) it is stated that:
[0062] The majority of small-molecule drugs in development today contain chiral centers, and according to Global Industry Analysts (GIA) nearly 95% of drugs will be chiral by 2020. GIA estimates that the global chiral technology market, which is dominated by pharmaceutical applications (followed by agrochemicals and flavors and fragrances), will reach $5.1 billion by 2017.
[0063] Because FDA requires manufacturers to investigate the properties (physicochemical, pharmacokinetic, etc.) of all enantiomers/diastereomers of chiral drugs to determine their individual safety and efficacy, the development of efficient chiral synthesis technologies remains a primary target for many academic and industrial researchers.
[0064] Thus, it is pertinent herein that one embodiment of the present invention has applications in chiral sensing for drugs development.
[0065] Because chiral sensing typically takes place in solutions, the effect of water on the optical activity of fabricated chiral plasmons was analyzed. After removal of surface oxides/contaminants using 5% HF, the RH-AgNPs-P arrays (P: 3-70 nm) are hydrophilic, with water contact angles ()<90; but the RH-AgNSs-215 array is hydrophobic, with a of 120 (
where the subscript Ext represents extinction, water the medium of water, air the medium of air, and m the number of alternating wetting/drying processes. The drying processes can be quantitatively characterized by
[0066] The multiple alternating wetting/drying processes consistently cause the LSPR extinction and CD peaks to have concurrent red/blue shifts (.sub.Ext,max.sub.CD,max,
[0067] The water effect of AgNPs was compared with that of AgNSs. The RH-AgNSs-215 array with a P of 215 nm has transverse (T) LSPR at a wavelength of roughly 370 nm and longitudinal (L) LSPR at roughly 520 nm (
[0068] Although slightly decreases with increasing m, RH-AgNSs-215 and RH-AgNPs-17 remain hydrophobic and hydrophilic, respectively (
[0069] Chiral nanoplasmons can be used to induce plasmonic chirality via chirality transfer. For example, when Au was deposited onto chiral AgNPs with a nominal thickness of 30 nm, the achiral Au nanocoatings cause an amplification of extinction in the visible region of 500-700 nm (
[0070] Furthermore, the chirality transfer from the underlying chiral NPs to the plasmonic nanocoatings occurs on diverse nanocoating materials, such as Cu (
Example 1
[0071] GLAD: In a physical vapor deposition system (JunSun Tech Co. Ltd., Taiwan) with a high vacuum of 10.sup.7-10.sup.6 Torr, Ag pellets (99.99%, Kurt J. Lesker) were evaporated at a rate of 0.3 nm/s as monitored by a quartz crystal microbalance, using an electron-beam accelerating voltage of 8.0 kV and emission current of 15-25 mA. At a deposition angle of 86 with respect to the direction normal to the substrate, Ag was deposited on sapphire (MTL Hong Kong) and Si wafer (Semiconductor Wafer, Inc.) over an area of 1.51.5 cm.sup.2. During deposition, an ethanol/water cooling system was used to control T.sub.sub at roughly 0 C. To produce RH/LH-AgNPs-P, the substrate was rotated clockwise/counterclockwise at a rate R.sub.r (in units of degrees per second, or /s) given by
where R.sub.d is the deposition rate on the substrate surface calibrated as 0.045 nm/s, and P is the helical pitch. To make P decrease from 70.4 to 3.2 nm, R.sub.r was controlled to increase from 0.23 to 5.0/s. The nominal P was calibrated by
where H is the helix height controlled to be roughly 100 nm, and n is the number of helical pitch equal to how many circles the substrate was rotated in. The engineering of structural parameters of RH/LH-AgNPs-P is summarized in Table 1. When R.sub.r was reduced to 0.11 and 0.07/s, Ag was sculptured to form AgNSs with P of 150 and 231 nm, respectively. At the deposition angle of 0 and T.sub.sub of 0 C., a substrate that was not rotated was deposited with 10-nm-thick Ag, leading to the generation of AgNPs without hidden chirality.
[0072] Measurement of CD and UV-Visible Extinction Spectra:
[0073] BioLogic CD (MOS 500) and DSM 1000 CD (Olis Inc.) were used to monitor the CD spectra of AgNPs and AgNSs deposited on sapphire under circularly polarized incident light along the substrate normal, respectively. The sample was rotated clockwise at 0.2 rpm to monitor CD in the wavelength range of 200-800 nm, to eliminate linear birefringence. Eight CD spectra were subsequently recorded and algebraically averaged to obtain a CD spectrum of the sample. UV-visible extinction spectra of all the samples were measured using BioLogic CD (MOS 500).
[0074] A liquid cell (with a path length of 1 mm and volume of approximately 0.08 ml) was used to evaluate the effect of aqueous solvent on the chiroptical activity of a sample. First, a sample deposited on sapphire was etched in 5% HF for 15 s to remove surface oxides/contaminants, and then sufficiently rinsed with DI water (18.2 M, Milli-Q reference water purification system fed with campus distilled water) and dried with N.sub.2. Second, the HF-treated sample was immediately transferred into the liquid cell to measure the CD and extinction spectra. Third, 0.08 ml of DI water was injected into the cell to completely immerse the sample in DI water (i.e., the wetting process), and then the CD and extinction spectra were recorded. Fourth, DI water was completely removed from the cell by sufficiently drying with N.sub.2 (i.e., the drying process) to record CD and extinction spectra. Fifth, multiple alternating wetting and drying processes were applied to study the reversibility of the aqueous solvent effect at the same spot on a sample.
[0075] Without substrate rotation, GLAD of Au (99.999%, Kurt J. Lesker), Cu (99.9999%, ZNXC, China) and Al (99.999%, ZNXC, China) was operated at a of 0 and T.sub.sub of 40 C., using an electron-beam accelerating voltage of 8.0 kV. R.sub.d of Au was controlled as 0.1 nm/s using emission current of 52-65 mA (Cu, 0.1 nm/s, 20-30 mA; Al, 0.1 nm/s, 35-45 mA). The nominal thickness of Au, Cu and Al were controlled to be 30 nm, monitored by the QCM.
[0076] Structure Characterization:
[0077] The as-deposited substrates were mechanically split, leaving the freshly exposed surfaces for SEM characterization (Oxford, LEO 1530).
[0078] Measurement of Water Contact Angle:
[0079] A 2-l droplet of DI water was applied to a sample to measure the contact angle using a contact angle meter (CA100A, Innuo Shanghai).
TABLE-US-00001 TABLE 1 Engineering of helical pitch P .Math. P.sub.d represents the designed P .Math. R.sub.d (the deposition rate of Ag) was controlled at 0.045 nm/s, calibrated at the deposition angle of 86 with respect to the direction normal to the substrate. For each sample, multiple (not less than 10) measurements were performed to evaluate H with algebraic average value and standard deviation. P.sub.d = 360 P = H/n R.sub.r R.sub.d/R.sub.r H (nm) n (nm) (/s ) (nm) LH RH LH RH LH RH 0.07 231.4 238 11 215 4 1 1 238 11 215 4 0.11 150.0 150 8 145 5 1 1 150 8 145 5 0.23 70.4 95 4 90 6 1.4 1.4 66 3 63 4 0.3 54.0 91 4 87 5 1.9 1.9 49 2 47 3 0.5 32.4 92 4 95 4 2.9 3.1 32 1 31 1 1.0 16.2 97 8 94 5 5.6 5.7 17 1 17 1 1.5 10.8 90 7 94 4 9.2 9.4 9.8 0.8 10.0 0.4 2.3 7.0 99 5 98 5 14.0 14.0 7.1 0.4 7.0 0.4 5.0 3.2 113 7 104 6 30.0 30.0 3.8 0.2 3.5 0.2
[0080] The LSPR spectral shift (.sub.Ext,max) can be described as:
where m is the sensitivity factor (in nm per refractive index unit, or nm/RIU), n is the refractive index of the medium, n.sub.air is the refraction index of air (equal to 1 RIU), T is the effective thickness of silver oxides on AgNPs, and I.sub.d is the electromagnetic field decay length. The above equation shows that the interception has an absolute value equal to the slope, but the sign opposite to the slope. Evaluated from the linear fitting of
[0081] The LSPR of AgNSs is composed of the transverse (T) mode at a wavelength of 365 nm and longitudinal (L) mode in the visible region (
l=d+{square root over ([n(Dd)].sup.2+(nPd).sup.2)}
[0082] However, the T mode shifts only slightly with the aspect ratio. RH-AgNSs-145 with a P of 145 nm have an aspect ratio of 4.6, and RH-AgNSs-215 with a P of 215 nm have an aspect ratio of 5.6. Both in the extinction and CD spectra, the increase in the aspect ratio from 4.6 to 5.6 causes the L mode to redshift from the wavelength of 422 to 518 nm but has little effect on the T mode (
INDUSTRIAL APPLICATION
[0083] Molecular scale chiroplasmonic nanostructures of the present invention find application in chiral sensing for determining enantiomers in chemical, biological, and pharmacological applications. Currently, more than 80% of pharmaceuticals on the market are chiral compounds. Usually, one enantiomeric configuration has a positive effect, but another may have a negative or even fatal side effect. Since 1992, the U.S. Food and Drug Administration has mandatorily required a full pharmacokinetic and toxicological evaluation of each stereoisomer of chiral drugs. It is therefore necessary to separate one enantiomer from another, and to differentiate one absolute configuration from another (i.e., enantiodifferentiation). The utilization of the invented plasmonic nanoparticles can essentially enhance the enantiodifferentiation, by amplifying the optical activity of pharmaceutical enantiomers.
[0084] In one aspect, the chiroplasmonic nanostructures have a helical pitch (P) less than the wire diameter of the helix to produce effects on the order of a molecular level to enable determination of smaller molecules.
[0085] Those skilled in the art will appreciate from the foregoing description that the broad techniques of the embodiments can be implemented in a variety of forms. Therefore, while the embodiments have been described in connection with particular examples thereof, the true scope of the embodiments should not be so limited since other modifications will become apparent to the skilled practitioner upon a study of the drawings, specification, and following claims.